Product Information
PIPERACIL-TAZOBACT 3.375 GM VL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $3.4926 per EA under NDC 65219043620. Its NADAC has been published 102 times since Jul 17, 2024.
Strength
3; .375 g/15mL; g/15mL
Manufacturer
Fresenius Kabi USA, LLCNDC
65219043620
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
1/21/2026
Active Ingredients
PIPERACILLIN SODIUM; TAZOBACTAM SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203719On Market Since
3/20/2023
Pharmacological Classes
Price Statistics
The NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has been published 102 times since Jul 17, 2024, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4926 per EA |
|---|---|
| All-time high | $4.5612 (Oct 16, 2024) |
| All-time low | $2.8072 (May 21, 2025) |
| 52-week high | $3.6157 |
| 52-week low | $2.9972 |
| Median price | $3.4926 |
| Average price | $3.5325 |
| Largest weekly change | -17.8% (Oct 23, 2024) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIPERACIL-TAZOBACT 3.375 GM VL?
The current National Average Drug Acquisition Cost (NADAC) for PIPERACIL-TAZOBACT 3.375 GM VL, manufactured by Fresenius Kabi USA, LLC, is $3.4926 per EA (NDC 65219043620), effective Jun 24, 2026.
How has the price of PIPERACIL-TAZOBACT 3.375 GM VL changed over time?
Over the history we have for it, the NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has declined 23.4%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for PIPERACIL-TAZOBACT 3.375 GM VL?
Since Jul 17, 2024, the NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has ranged from a low of $2.8072 (May 21, 2025) to a high of $4.5612 (Oct 16, 2024), with a median of $3.4926 per EA.
Are there cheaper alternatives to PIPERACIL-TAZOBACT 3.375 GM VL?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PIPERACIL-TAZOBACT 3.375 GM VL, but none are currently priced below it.
Who manufactures PIPERACIL-TAZOBACT 3.375 GM VL?
PIPERACIL-TAZOBACT 3.375 GM VL (NDC 65219043620) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification